Rockefeller Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Rockefeller Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.3M	Sell	107,230 -19,876	-16%	-$2.04M	0.02%	722
2026 Q1	$13.9M	Sell	127,106 -38,450	-23%	-$3.66M	0.02%	559
2025 Q4	$13.4M	Sell	165,556 -100,923	-38%	-$8.69M	0.02%	557
2025 Q3	$23.3M	Sell	266,479 -22,995	-8%	-$2.05M	0.05%	368
2025 Q2	$24M	Buy	289,474 +111,375	+63%	+$9.31M	0.05%	332
2025 Q1	$14.9M	Buy	178,099 +93,582	+111%	+$8.71M	0.04%	443
2024 Q4	$7.79M	Buy	+84,517	New	+$8.13M	0.02%	609
2023 Q1	–	Sell	-7	Closed	–	–	3063
2022 Q4	$0	Sell	7 -203	-97%	-$9.51K	﹤0.01%	4058
2022 Q3	$10K	Buy	210 +40	+24%	+$2K	﹤0.01%	3086
2022 Q2	$7K	Sell	170 -20	-11%	-$895	﹤0.01%	3303
2022 Q1	$8K	Buy	+190	New	+$8.5K	﹤0.01%	3162

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Rockefeller Capital Management's LMAT Position: Q2 2026 in Review

Rockefeller Capital Management reduced its LeMaitre Vascular (LMAT) stake by 16% in Q2 2026, selling an estimated $2.04M and leaving 107,230 shares worth $10.3M. The position accounts for 0.02% of the portfolio, ranked #722.

Rockefeller Capital Management first reported a position in LMAT in Q1 2022 and has held it in 11 quarters since. The position peaked at $24M in Q2 2025. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Rockefeller Capital Management held 107,230 shares of LeMaitre Vascular worth $10.3M as of Q2 2026.
Rockefeller Capital Management sold 19,876 LeMaitre Vascular shares in Q2 2026, an estimated $2.04M.
LeMaitre Vascular made up 0.02% of Rockefeller Capital Management's portfolio in Q2 2026, its #722 holding.
Rockefeller Capital Management first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 11 quarters since.
Rockefeller Capital Management's LeMaitre Vascular position peaked at $24M in Q2 2025.
327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.